Abstract

The paper outlines the role of oxytocin in regulating interpersonal communication of patients with borderline personality disorder (BPD). According to the neuropeptide model of borderline disorder, changes in the regulation of the oxytocin secretion system are indicated as a potential mechanism of interpersonal deficits, which are the core of that disorder Numerous studies have confirmed the reduced level of oxytocin in this group of people. In view of that finding, in the last dozen or so years, there have been attempts at intranasal administration of oxytocin as a potential pharmacotherapy strategy dedicated to reducing the symptoms of BPD in the interpersonal area. However, the conclusions of the research in this field are not definitive to date.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call